Kobalava Zh D, Kotovskaia Iu V, Bagmanova N Kh, Fediunina E Iu, Karaulova Iu L
Kardiologiia. 2011;51(7):27-31.
Efficacy and tolerability of fixed amlodipine/valsartan combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology. All patients had indications for antihypertensive therapy and were randomized either to fixed combination amlodipine/valsartan (n=43) or to therapy which corresponded to the hospital formulary (n=43). Correction of antihypertensive therapy was performed by treating physician at daily rounds. Self-control of blood pressure (BP) was performed by patients with the use of UA767PC apparatus. Results of BP self-control were compared with clinical measurements in order to detect concealed inefficacy of treatment. Results. Rate of achievement of target BP with fixed combination amlodipine/valsartan (93%) was comparable with that on traditional therapy (90%). But the use of fixed combination amlodipine/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, p<0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, p<0.05). Conclusions. We have demonstrated appropriateness of inhospital administration of fixed amlodipine/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.
对86例在内科或心脏病科住院的高血压病患者研究了氨氯地平/缬沙坦固定复方制剂的疗效和耐受性。所有患者均有进行抗高血压治疗的指征,并被随机分为氨氯地平/缬沙坦固定复方制剂组(n = 43)或采用符合医院处方集的治疗组(n = 43)。抗高血压治疗的调整由负责治疗的医师在每日查房时进行。患者使用UA767PC仪器进行血压自我监测。将血压自我监测结果与临床测量结果进行比较,以检测治疗中潜在的无效情况。结果:氨氯地平/缬沙坦固定复方制剂达到目标血压的比例(93%)与传统治疗(90%)相当。但与传统治疗相比,使用氨氯地平/缬沙坦固定复方制剂时,临床和自我测量的血压更低,达到目标血压更快(分别为5.8±2.3天和9.2±1.8天,p<0.05),使用的抗高血压药物数量更少(分别为2.5±0.6种和3.0±0.9种),治疗中潜在无效的发生率更低(分别为12%和31%,p<0.05)。结论:我们已经证明在医院内给予氨氯地平/缬沙坦固定复方制剂是合适的,这种方法能够在更短时间内达到目标血压,使用更少的抗高血压药物,并减少治疗中潜在的无效情况。